Literature DB >> 31011768

Pseudoprogression on PSMA PET imaging of a mCRPC patient under anti-PD1 treatment.

Larissa Bastos Costa1, Marcelo Araujo Queiroz2,3, Felipe de Galiza Barbosa2, Rafael Fernandes Nunes2, José Flávio Gomes Marin2,3, Carlos Dzik4, Carlos Alberto Buchpiguel2,3.   

Abstract

Entities:  

Year:  2019        PMID： 31011768     DOI： 10.1007/s00259-019-04328-1

Source DB:  PubMed          Journal:  Eur J Nucl Med Mol Imaging        ISSN： 1619-7070            Impact factor:   9.236


× No keyword cloud information.
  5 in total

Review 1.  Immunotherapy of Prostate Cancer: Facts and Hopes.

Authors:  Marijo Bilusic; Ravi A Madan; James L Gulley
Journal:  Clin Cancer Res       Date:  2017-06-29       Impact factor: 12.531

Review 2.  Therapy assessment in prostate cancer using choline and PSMA PET/CT.

Authors:  Francesco Ceci; Ken Herrmann; Boris Hadaschik; Paolo Castellucci; Stefano Fanti
Journal:  Eur J Nucl Med Mol Imaging       Date:  2017-05-25       Impact factor: 9.236

3.  Pharmacological upregulation of prostate-specific membrane antigen (PSMA) expression in prostate cancer cells.

Authors:  Benedikt Kranzbühler; Souzan Salemi; Christoph A Umbricht; Cristina Müller; Irene A Burger; Tullio Sulser; Daniel Eberli
Journal:  Prostate       Date:  2018-04-06       Impact factor: 4.104

4.  Analysis of the Prevalence of Microsatellite Instability in Prostate Cancer and Response to Immune Checkpoint Blockade.

Authors:  Wassim Abida; Michael L Cheng; Joshua Armenia; Sumit Middha; Karen A Autio; Hebert Alberto Vargas; Dana Rathkopf; Michael J Morris; Daniel C Danila; Susan F Slovin; Emily Carbone; Ethan S Barnett; Melanie Hullings; Jaclyn F Hechtman; Ahmet Zehir; Jinru Shia; Philip Jonsson; Zsofia K Stadler; Preethi Srinivasan; Vincent P Laudone; Victor Reuter; Jedd D Wolchok; Nicholas D Socci; Barry S Taylor; Michael F Berger; Philip W Kantoff; Charles L Sawyers; Nikolaus Schultz; David B Solit; Anuradha Gopalan; Howard I Scher
Journal:  JAMA Oncol       Date:  2019-04-01       Impact factor: 31.777

Review 5.  FDG PET/CT for assessing tumour response to immunotherapy : Report on the EANM symposium on immune modulation and recent review of the literature.

Authors:  Nicolas Aide; Rodney J Hicks; Christophe Le Tourneau; Stéphanie Lheureux; Stefano Fanti; Egesta Lopci
Journal:  Eur J Nucl Med Mol Imaging       Date:  2018-10-05       Impact factor: 9.236
  5 in total
  5 in total

Review 1.  How to differentiate pseudoprogression from true progression in cancer patients treated with immunotherapy.

Authors:  Yiming Ma; Qiwei Wang; Qian Dong; Lei Zhan; Jingdong Zhang
Journal:  Am J Cancer Res       Date:  2019-08-01       Impact factor: 6.166

2.  Immune cell gene expression signatures in diffuse glioma are associated with IDH mutation status, patient outcome and malignant cell state, and highlight the importance of specific cell subsets in glioma biology.

Authors:  Bharati Mehani; Saleembhasha Asanigari; Hye-Jung Chung; Karen Dazelle; Arashdeep Singh; Sridhar Hannenhalli; Kenneth Aldape
Journal:  Acta Neuropathol Commun       Date:  2022-02-10       Impact factor: 7.801

Review 3.  NIR fluorescence imaging and treatment for cancer immunotherapy.

Authors:  Homan Kang; Min-Woong Kang; Satoshi Kashiwagi; Hak Soo Choi
Journal:  J Immunother Cancer       Date:  2022-07       Impact factor: 12.469

Review 4.  The Role of Histology-Agnostic Drugs in the Treatment of Metastatic Castration-Resistant Prostate Cancer.

Authors:  Giovanni Maria Iannantuono; Francesco Torino; Roberto Rosenfeld; Simona Guerriero; Manuela Carlucci; Stefano Sganga; Barbara Capotondi; Silvia Riondino; Mario Roselli
Journal:  Int J Mol Sci       Date:  2022-08-01       Impact factor: 6.208

5.  A case of microsatellite instability-high clinically advanced castration-resistant prostate cancer showing a remarkable response to pembrolizumab sustained over at least 18 months.

Authors:  Kosuke Shimizu; Takeshi Sano; Kei Mizuno; Takuro Sunada; Noriyuki Makita; Hiroki Hagimoto; Takayuki Goto; Atsuro Sawada; Masakazu Fujimoto; Kentaro Ichioka; Osamu Ogawa; Takashi Kobayashi; Shusuke Akamatsu
Journal:  Cold Spring Harb Mol Case Stud       Date:  2022-06-22
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.